Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.ASTH · Entity 4538 | COO and CFO | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 155,728 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Tax withholding · Disposed 2,092 · Balance 155,728 F1: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026. F2: Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026.
F2: Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 10:01 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 2,092 | $35.88 | $75,060.96 |
DisclosureSEC source: 0001104659-26-113838 · tm2626980d1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,728 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026. F2 · balance_after: Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027. Read SEC document |
| September 05, 2026 Filed Sep 8, 2026 20:41 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 1,790 | $38.47 | $68,861.30 |
DisclosureSEC source: 0001104659-26-105932 · tm2625011-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,820 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026. F2 · balance_after: Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027. Read SEC document |
| May 16, 2026 Filed May 18, 2026 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 8,155 | $38.26 | $312,010.30 |
DisclosureSEC source: 0001104659-26-063197 · tm2614898-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,610 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026. F2 · balance_after: Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 3,870 | $29.07 | $112,500.90 |
DisclosureSEC source: 0001104659-26-043808 · tm2611888-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,765 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026. F2 · balance_after: Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 21:36 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 2,092 | $25.05 | $52,404.60 |
DisclosureSEC source: 0001104659-26-039686 · tm2611155-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,635 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 1,240 | $25.07 | $31,086.80 |
DisclosureSEC source: 0001104659-26-025232 · tm268271-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,727 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 1,979 | $27.77 | $54,956.83 |
DisclosureSEC source: 0001104659-25-097117 · tm2527993-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,967 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:36 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 1,694 | $29.70 | $50,311.80 |
DisclosureSEC source: 0001104659-25-088648 · tm2525521-2_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,946 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:12 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 10,035 | $27.18 | $272,751.30 |
DisclosureSEC source: 0001104659-25-050542 · tm2515547-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,640 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 2,683 | $34.05 | $91,356.15 |
DisclosureSEC source: 0001104659-25-035506 · tm2512412-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,675 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 21:11 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 1,394 | $30.02 | $41,847.88 |
DisclosureSEC source: 0001104659-25-031753 · tm2511480-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,358 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which will vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025. Read SEC document |
| March 05, 2025 Filed Mar 8, 2025 01:05 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 26,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-021867 · tm258649-3_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,752 F1 · shares: Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on September 5, 2025. F2 · balance_after: Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which will vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 27,303 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 21:38 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 691 | $46.96 | $32,449.36 |
DisclosureSEC source: 0001104659-24-116863 · tm2428142-4_4seq1.xml · nonDerivative · entry 2 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,051 F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on November 8, 2024. F3 · balance_after: Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which will vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 27,303 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025 (subject to continuous employment with the Issuer). Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 21:38 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 15,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-116863 · tm2428142-4_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,742 F1 · shares: Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal installments, with the first installment vesting on November 8, 2024, and the remaining shares vesting in seven equal semi-annual installments beginning on April 2, 2025. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:16 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 7,051 | $41.13 | $290,007.63 |
DisclosureSEC source: 0001104659-24-063017 · tm2414810-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,232 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which vest on May 16, 2025; and (iii) 45,606 shares, which vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). Read SEC document |
| April 14, 2024 Filed Apr 22, 2024 10:00 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 7,993 | $40.72 | $325,474.96 |
DisclosureSEC source: 0001104659-24-049580 · tm2412001-2_4seq1.xml · nonDerivative · entry 2 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,283 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 29, 2024 and April 14, 2024, respectively. F3 · balance_after: Includes 84,356 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; and (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:13 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 15,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-043690 · tm2411040-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,783 F1 · shares: Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 2, 2024 (the six month anniversary of the grant date). F2 · balance_after: Includes 152,372 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). Read SEC document |
| March 29, 2024 Filed Apr 22, 2024 10:00 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 6,507 | $41.99 | $273,228.93 |
DisclosureSEC source: 0001104659-24-049580 · tm2412001-2_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,276 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 29, 2024 and April 14, 2024, respectively. F2 · balance_after: Total holdings includes 15,692 restricted stock units that were granted on April 2, 2024, as previously disclosed in a Form 4 filed on April 4, 2024. Read SEC document |
| May 16, 2023 Filed May 26, 2023 00:25 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 130,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-23-000033 · primary_doc.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,671 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest as follows: (i) 9,121 of the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 17, 2024; (ii) 60,808 of the shares shall vest in six equal (as nearly as possible) semi-annual installments, beginning on October 12, 2023; and (iii) the remaining 60,803 shares shall vest upon achievement of certain pre-established performance goals. Read SEC document |
| May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 60,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 4 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,091 F4 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals. F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. F6 · balance_after: Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals. Read SEC document |
| May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 60,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 3 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,288 F3 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024. F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. Read SEC document |
| May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 9,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 2 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,480 F2 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024. F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. Read SEC document |
| May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerCommon Stock | 48,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,359 F1 · shares: Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings. Read SEC document |
| April 14, 2023 Filed Oct 17, 2023 20:15 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 2,494 | $39.06 | $97,415.64 |
DisclosureSEC source: 0001104659-23-109615 · tm2326115-1_4seq1.xml · nonDerivative · entry 1 Basho Chandan · CIK 0001929126 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,445 F1 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on April 14, 2023. F2 · balance_after: Includes 69,726 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; and (ii) 48,086 shares, which vest upon achievement of certain pre-established performance goals. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.